MLchartDataset catalogue

panitumumab-IRDye800

Term · Oncology and biomedicine · MLC-T-ONC-015795

An imaging agent composed of panitumumab, a humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody, conjugated to the near-infrared (NIR) fluorescent dye IRDye800, that can potentially be used for the imaging of EGFR-expressing tumors. Upon administration of panitumumab-IRDye800, the panitumumab moiety targets and binds to EGFR expressed on tumor cells. Upon fluorescence imaging of IRDye800, the tumor cells can be detected.

Table 1. Record
IdentifierMLC-T-ONC-015795
FieldOncology and biomedicine
Synonymspanitumumab IRDye 800; IRDye800-panitumumab conjugate
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015795",
  "term": "panitumumab-IRDye800",
  "field": "Oncology and biomedicine",
  "definition": "An imaging agent composed of panitumumab, a humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody, conjugated to the near-infrared (NIR) fluorescent dye IRDye800, that can potentially be used for the imaging of EGFR-expressing tumors. Upon administration of panitumumab-IRDye800, the panitumumab moiety targets and binds to EGFR expressed on tumor cells. Upon fluorescence imaging of IRDye800, the tumor cells can be detected.",
  "synonyms": [
    "panitumumab IRDye 800",
    "IRDye800-panitumumab conjugate"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/panitumumab-irdye800/"
}

Record 12,584 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.